CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Pharmathene, Inc  (PIP)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Pharmathene Inc's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

Return On Assets (Mar 31 2017)
I. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Total Assets Change 4.36 % 572.57 % 23.5 % -26.43 % -9.63 %
Y / Y Net Income Change - - - - -
Return On Assets (TTM) 219.02 % 221.79 % 19.47 % - -
Total Ranking # 24 # # 28 # 172 #
Seq. Total Assets Change -85.25 % 403.16 % 49.09 % -5.68 % -4.94 %
Seq. Net Income Change - - - - -


Roa Comment
Pharmathene, Inc yielded Return on Asset in I. Quarter above company average, at 219.02 %.

ROA decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 3 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from to 24.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 1
Sector # 4
S&P 500 # 24

Return On Assets Statistics
High Average Low
221.79 %
153.43 %
19.47 %
(Sep 30 2016)   (June 30. 2016)


You need to upgrade your Flash Player
Financial Statements
Pharmathene Inc's Equity $ 18 Millions PIP's Balance sheet
Pharmathene Inc's Income $ -2 Millions Quarterly PIP's Income Statement
PIP's Income by Division See PIP's Income by Division

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PIP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for PIP's Competitors
Roa for Pharmathene Inc's Suppliers
Return On Asstes for PIP's Customers

You may also want to know
PIP's Roi PIP's Inventory Turnover Ratio PIP's Growth Rates PIP's Dividend Comparisons
PIP's Annual Roi PIP's Profitability Ratios PIP's Asset Turnover Ratio PIP's Dividend Growth
PIP's Roe PIP's Valuation Ratios PIP's Financial Strength Ratios PIP's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2017, within Healthcare Sector ROA
Nanovibronix, Inc.  522.93 %
Regenerx Biopharmaceuticals Inc  349.48 %
Pharmathene, Inc  219.02 %
Prophase Labs, Inc.  182.12 %
Ophthalix, Inc.  169.96 %
Steadymed Ltd.  145.38 %
International Stem Cell Corp  137.42 %
Capstone Therapeutics Corp.  133.50 %
Greenestone Healthcare Corp  127.56 %
Mannkind Corp  125.49 %
Tenax Therapeutics, Inc.  100.61 %
Neurometrix, Inc.  77.36 %
Elite Pharmaceuticals Inc  70.86 %
Apricus Biosciences, Inc.  61.49 %
Biotime Inc  59.79 %
Eagle Pharmaceuticals, Inc.  57.27 %



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com